脂肪性肝炎
脂肪变性
未折叠蛋白反应
甾醇调节元件结合蛋白
串扰
细胞生物学
脂肪肝
内分泌学
化学
内科学
癌症研究
生物
医学
胆固醇
内质网
甾醇
光学
物理
疾病
作者
Ju Youn Kim,Lily Q. Wang,Valentina C. Sladky,Tae Gyu Oh,Junlai Liu,Kaitlyn Trinh,Felix Eichin,Michael Downes,Mojgan Hosseini,Étienne Jacotot,Ronald M. Evans,Andreas Villunger,Michael Karin
出处
期刊:Cell Metabolism
[Elsevier]
日期:2022-08-29
卷期号:34 (10): 1548-1560.e6
被引量:21
标识
DOI:10.1016/j.cmet.2022.08.005
摘要
Sterol deficiency triggers SCAP-mediated SREBP activation, whereas hypernutrition together with ER stress activates SREBP1/2 via caspase-2. Whether these pathways interact and how they are selectively activated by different dietary cues are unknown. Here, we reveal regulatory crosstalk between the two pathways that controls the transition from hepatosteatosis to steatohepatitis. Hepatic ER stress elicited by NASH-inducing diets activates IRE1 and induces expression of the PIDDosome subunits caspase-2, RAIDD, and PIDD1, along with INSIG2, an inhibitor of SCAP-dependent SREBP activation. PIDDosome assembly activates caspase-2 and sustains IRE1 activation. PIDDosome ablation or IRE1 inhibition blunt steatohepatitis and diminish INSIG2 expression. Conversely, while inhibiting simple steatosis, SCAP ablation amplifies IRE1 and PIDDosome activation and liver damage in NASH-diet-fed animals, effects linked to ER disruption and preventable by IRE1 inhibition. Thus, the PIDDosome and SCAP pathways antagonistically modulate nutrient-induced hepatic ER stress to control non-linear transition from simple steatosis to hepatitis, a key step in NASH pathogenesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI